Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity

[1]  T. Tsuruo,et al.  Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. , 2008, The American journal of pathology.

[2]  M. Raes,et al.  LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells. , 2008, American journal of physiology. Cell physiology.

[3]  G. Mills,et al.  Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation. , 2008, Biochimica et biophysica acta.

[4]  S. Pyne,et al.  Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination. , 2008, Biochimica et biophysica acta.

[5]  J. Altman,et al.  Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection , 2008, Nature.

[6]  V. Brinkmann,et al.  Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. , 2008, Cancer letters.

[7]  Min Goo Lee,et al.  Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92* , 2008, Journal of Biological Chemistry.

[8]  Akira Shiraishi,et al.  Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. , 2008, Biochemical and biophysical research communications.

[9]  James I. Fells,et al.  Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors* , 2008, Journal of Biological Chemistry.

[10]  M. Gunn,et al.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs , 2008, Nature Immunology.

[11]  M. Nöthen,et al.  G protein–coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth , 2008, Nature Genetics.

[12]  A. Shiraishi,et al.  The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. , 2007, Biochemical and biophysical research communications.

[13]  Robert V Farese,et al.  LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA) , 2007, Journal of leukocyte biology.

[14]  H. Ikeda,et al.  Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. , 2007, Analytical biochemistry.

[15]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[16]  S. Georas,et al.  Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  A. Dubin,et al.  LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation* , 2007, Journal of Biological Chemistry.

[18]  S. Georas,et al.  Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells. , 2006, Stem cells and development.

[19]  S. Offermanns,et al.  Lysophospholipids Control Integrin-dependent Adhesion in Splenic B Cells through Gi and G12/G13 Family G-proteins but Not through Gq/G11* , 2006, Journal of Biological Chemistry.

[20]  U. V. von Andrian,et al.  Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration. , 2006, The New England journal of medicine.

[21]  Y. Kishi,et al.  Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[22]  A. Dubin,et al.  GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5* , 2006, Journal of Biological Chemistry.

[23]  B. Olde,et al.  Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  M. Idzko,et al.  IL‐6 and IL‐8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids , 2006, Journal of leukocyte biology.

[25]  C. Mummery,et al.  Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development , 2006, Molecular and Cellular Biology.

[26]  Naděžda Brdičková,et al.  CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs , 2006, Nature.

[27]  J. Boyce,et al.  IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells1 , 2005, The Journal of Immunology.

[28]  Ying Xu,et al.  Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients , 2005, Science.

[29]  K. Kikuchi,et al.  Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate* , 2005, Journal of Biological Chemistry.

[30]  Hiroshi Suzuki,et al.  LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing , 2005, Nature.

[31]  J. Chun,et al.  Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor γ2* , 2005, Journal of Biological Chemistry.

[32]  R. Proia,et al.  Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit , 2005, The Journal of experimental medicine.

[33]  D. Friend,et al.  Lysophosphatidic acid accelerates the development of human mast cells. , 2004, Blood.

[34]  E. Goetzl,et al.  Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. , 2004, The Journal of clinical investigation.

[35]  H. Ueda,et al.  Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling , 2004, Nature Medicine.

[36]  Chunxiang Zhang,et al.  Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation , 2004, The Journal of experimental medicine.

[37]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[38]  S. Georas,et al.  Involvement of Phospholipase D2 in Lysophosphatidate-induced Transactivation of Platelet-derived Growth Factor Receptor-β in Human Bronchial Epithelial Cells* , 2003, Journal of Biological Chemistry.

[39]  G. Mills,et al.  The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.

[40]  R. Homer,et al.  Cytokine regulation of IL-13Ra2 and IL-13Ra1 in vivo and in vitro , 2003 .

[41]  J. C. Hinshaw,et al.  Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Di Virgilio,et al.  The Influence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells , 2002, The Journal of Immunology.

[43]  J. Chun,et al.  Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 , 2002, Molecular and Cellular Biology.

[44]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[45]  K. Waku,et al.  2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. , 2002, Archives of biochemistry and biophysics.

[46]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[47]  T. Hla,et al.  Lysophospholipids--Receptor Revelations , 2001, Science.

[48]  J. Chun,et al.  The LPA receptors. , 2001, Prostaglandins & other lipid mediators.

[49]  E. Goetzl,et al.  Altered expression and functional profile of lysophosphatidic acid receptors in mitogen‐activated human blood T lymphocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  J. Weiner,et al.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. Goetzl,et al.  Cutting Edge: Differential Constitutive Expression of Functional Receptors for Lysophosphatidic Acid by Human Blood Lymphocytes1 , 2000, The Journal of Immunology.

[52]  C. Turck,et al.  Gelsolin Binding and Cellular Presentation of Lysophosphatidic Acid* , 2000, The Journal of Biological Chemistry.

[53]  M. Tsao,et al.  Autotaxin expression in non-small-cell lung cancer. , 1999, American journal of respiratory cell and molecular biology.

[54]  J. Vandekerckhove,et al.  Gelsolin and functionally similar actin‐binding proteins are regulated by lysophosphatidic acid , 1998, The EMBO journal.

[55]  O. Kranenburg,et al.  Lysophosphatidic acid: G-protein signalling and cellular responses. , 1997, Current opinion in cell biology.

[56]  E. Goetzl,et al.  Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. , 1997, Biochemical and biophysical research communications.

[57]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[58]  V. Casolaro,et al.  Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[59]  J. Cyster,et al.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.